MoneyWorks4Me

The sales is pegged at Rs. 1751.80 millions for the September 2025 quarter. The mentioned figure indicates decline with the sales recorded at Rs. 2079.30 millions during the year-ago period.The Net Profit of the company registered a slight decline of -2.98% to Rs. 1025.90  millions from Rs. 1057.40 millions.Operating Profit reported a sharp decline to 1350.70 millions from 1411.70 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202509 202409 % Var 202509 202409 % Var 202503 202403 % Var
Sales 1751.80 2079.30 -15.75 3577.50 3935.70 -9.10 7524.10 6250.90 20.37
Other Income 592.20 430.10 37.69 912.50 645.10 41.45 1345.90 1058.40 27.16
PBIDT 1350.70 1411.70 -4.32 2537.10 2440.50 3.96 4665.60 3929.20 18.74
Interest 0.50 0.20 150.00 0.90 0.40 125.00 1.20 1.00 20.00
PBDT 1350.20 1411.50 -4.34 2536.20 2440.10 3.94 4664.40 3928.20 18.74
Depreciation 60.20 64.90 -7.24 121.60 126.70 -4.03 247.70 270.80 -8.53
PBT 1290.00 1346.60 -4.20 2414.60 2313.40 4.37 4416.70 3657.40 20.76
TAX 264.10 289.20 -8.68 529.80 530.60 -0.15 1021.80 820.30 24.56
Deferred Tax -3.60 -2.30 56.52 -7.00 -6.60 6.06 -7.20 -40.90 -82.40
PAT 1025.90 1057.40 -2.98 1884.80 1782.80 5.72 3394.90 2837.10 19.66
Equity 152.00 152.00 0.00 152.00 152.00 0.00 152.00 151.90 0.07
PBIDTM(%) 77.10 67.89 13.57 70.92 62.01 14.37 62.01 62.86 -1.35

Caplin Point Labs. Share Price

2480.60 -17.65 (-0.71%)
14-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1924.90
Dr. Reddys Labs. 1202.00
Cipla 1450.00
Lupin 2235.00
Zydus Lifesciences 1140.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: